Home/Filings/4/0001140361-18-021807
4//SEC Filing

Samuels Camille D 4

Accession 0001140361-18-021807

CIK 0001463361other

Filed

May 3, 8:00 PM ET

Accepted

May 4, 6:14 PM ET

Size

6.4 KB

Accession

0001140361-18-021807

Insider Transaction Report

Form 4
Period: 2018-05-02
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-05-02+40,67840,678 total
    Exercise: $17.00Exp: 2028-05-01Common Stock (40,678 underlying)
Footnotes (2)
  • [F1]The shares underlying the option shall vest as to 1/3rd of the underlying shares on each anniversary of May 2, 2018, subject to the Non-Employee Director continuing to serve on the Board through such vesting date.
  • [F2]The reporting person is a member of VR Management, LLC (the "Management Company"). Under an agreement between the reporting person and the Management Company, the reporting person is deemed to hold the reported option and the shares underlying the option for the sole benefit of the Management Company and must exercise the reported option solely upon the direction of the Management Company, which is entitled to the shares underlying the option. The Management Company may be deemed the indirect beneficial owner of the shares underlying the option, and the reporting person may be deemed the indirect beneficial owner of the reported shares underlying the option through her interest in the Management Company. The reporting person disclaims beneficial ownership of the reported shares except to the extent of her pecuniary interest therein.

Documents

1 file

Issuer

Unity Biotechnology, Inc.

CIK 0001463361

Entity typeother

Related Parties

1
  • filerCIK 0001354034

Filing Metadata

Form type
4
Filed
May 3, 8:00 PM ET
Accepted
May 4, 6:14 PM ET
Size
6.4 KB